Close this search box.

Potential at-home ketamine treatment for severe depression


An experimental slow-release ketamine capsule, potentially taken at home, offers new hope for individuals with severe, treatment-resistant depression. This innovative approach could revolutionize treatment by making it more accessible and cost-effective.

Understanding ketamine’s role in treating severe depression

  • Ketamine has shown effectiveness in individuals who have not responded to traditional antidepressants.
  • Current treatments involve clinical supervision due to administration via nasal spray or injection, requiring patients to remain in clinics for monitoring, thus increasing costs.
  • A recent study published in Nature Medicine explores a slow-release tablet form of ketamine that patients could safely use at home, potentially reducing treatment costs and side effects associated with other forms of administration.

Study insights and future potential

The study, known as the BEDROC trial, involved 168 participants with treatment-resistant depression. They were divided into groups receiving different doses of the experimental drug R-107, with most doses administered at home. Results indicated significant improvement in depression symptoms, particularly at higher doses compared to a placebo.

While the treatment was generally well-tolerated, some participants experienced side effects such as dizziness and headaches. Importantly, the study noted an absence of severe cardiovascular side effects, a common issue with other ketamine forms.

The mechanism behind ketamine’s effects

Ketamine acts as an NMDA receptor antagonist, leading to increased glutamate transmission and promoting synaptic plasticity, which helps alleviate depressive symptoms quickly. This rapid action is crucial for those struggling with severe depression and suicidal thoughts, offering potential relief within hours.

Looking ahead: The road to clinical use

Despite promising results, extensive further research is necessary. Douglas Pharmaceuticals plans to conduct larger, multi-site trials to confirm these findings and move toward FDA approval. If successful, this at-home ketamine treatment could become a life-changing option for those with few alternatives.

The development of at-home ketamine treatments represents a significant advancement in the fight against severe depression, combining potential efficacy with greater accessibility.